Henry Schein Dental Company is a leading provider of dental products and services, catering primarily to dental professionals and practices
The company offers a comprehensive range of solutions including dental equipment, consumable supplies, technology products, and practice management tools. In addition to its product offerings, Henry Schein Dental also provides training and support services, helping dental practitioners enhance their operations and improve patient care. With a strong emphasis on innovation and customer service, the company plays a vital role in advancing the dental industry and supporting the success of dental health providers.
The private equity firm will also be able to purchase additional shares via open market purchases, up to a total equity stake of 14.9% in Henry Schein.
BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting growth and recovery potential.
Patient Square Capital agrees to buy Patterson Companies for $4.1 billion. Analysts predict minimal regulatory hurdles and a strong bid unlikely to face competition.
Henry Schein posts Q3 adjusted EPS of $1.23, topping forecasts, while sales of $3.17 billion fall short. The company revises full-year EPS guidance upwards.
Henry Schein Q2 adjusted EPS fell 6.1% to $1.23, beating the $1.22 consensus. Sales grew 1% to $3.10 billion, missing the $3.27B forecast. The company announced a restructuring plan for $75-$100 million in savings and authorized a $500 million share repurchase. Updated 2024 guidance reflects slower recovery from a cyber incident.
